Your browser doesn't support javascript.
loading
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
Einbinder, Yael; Perl, Jeffrey; Nacasch, Naomi; Bnaya, Alon; Shavit, Linda; Erez, Daniel; Shashar, Moshe; Halperin, Tamar; Grupper, Ayelet; Benchetrit, Sydney; Wand, Ori; Cohen-Hagai, Keren.
Afiliación
  • Einbinder Y; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
  • Perl J; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nacasch N; Division of Nephrology, St. Michael's Hospital and the Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Bnaya A; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
  • Shavit L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Erez D; Institute of Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Shashar M; Hebrew University of Jerusalem, Jerusalem, Israel.
  • Halperin T; Institute of Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Grupper A; Hebrew University of Jerusalem, Jerusalem, Israel.
  • Benchetrit S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wand O; Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel.
  • Cohen-Hagai K; Department of Nephrology and Hypertension, Laniado Hospital, Netanya, Israel.
Am J Nephrol ; 53(7): 586-590, 2022.
Article en En | MEDLINE | ID: mdl-35850101
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Nephrol Año: 2022 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Nephrol Año: 2022 Tipo del documento: Article País de afiliación: Israel